WellPoint’s New Quality Initiative Aims to Improve Cancer Outcomes, Promote Access to Evidence-Based and Cost-Effective Care

INDIANAPOLIS--(BUSINESS WIRE)--May 28, 2014-- Affiliated health plans of WellPoint, Inc. will be introducing an innovative quality initiative beginning July 1 that will allow oncologists to compare planned cancer treatment regimens against evidence-based clinical criteria and potentially receive enhanced reimbursement.

The WellPoint Cancer Care Quality Program, developed in collaboration with WellPoint subsidiary, AIM Specialty Health, identifies certain cancer treatment pathways selected based upon current medical evidence, peer-reviewed published literature, consensus guidelines, and WellPoint’s clinical policies, to support oncologists in identifying cancer treatment therapies that are highly effective and provide greater value.

WellPoint, Inc | Investor Relations | Press Release